CAR T Cell Therapy Market Transforming Hematologic Malignancy Treatment
Market Overview The CAR T cell therapy market represents one of oncology's most transformative advances, harnessing patient immune systems to target and eliminate cancer cells through genetically engineered chimeric antigen receptor T cells. Initially approved for refractory B-cell malignancies, this personalized cellular therapy has demonstrated remarkable efficacy in patients who have...
0 Comments 0 Shares 250 Views 0 Reviews